{"version":"1.0","type":"link","title":"Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.","author_name":"Zhang X 외","author_url":"https://prs-insight.online/author/Zhang%20X","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/111189","thumbnail_width":1200,"thumbnail_height":630}